Adverse events of inactivated COVID-19 vaccine in HIV-infected adults

This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Songjie, Zhang, Yubin, Ming, Fangzhao, Zou, Shi, Wu, Mengmeng, Guo, Wei, Tang, Weiming, Liang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643182/
https://www.ncbi.nlm.nih.gov/pubmed/34863210
http://dx.doi.org/10.1186/s12981-021-00416-1
_version_ 1784609828806590464
author Wu, Songjie
Zhang, Yubin
Ming, Fangzhao
Zou, Shi
Wu, Mengmeng
Guo, Wei
Tang, Weiming
Liang, Ke
author_facet Wu, Songjie
Zhang, Yubin
Ming, Fangzhao
Zou, Shi
Wu, Mengmeng
Guo, Wei
Tang, Weiming
Liang, Ke
author_sort Wu, Songjie
collection PubMed
description This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccination dose. The overall AE frequency was 22.8% after dose one, which was higher than after dose two (10.2%) (P < 0.001). No severe side event or vaccine safety concern was observed. Our finding was essential in reducing vaccine hesitancy among PLWH.
format Online
Article
Text
id pubmed-8643182
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86431822021-12-06 Adverse events of inactivated COVID-19 vaccine in HIV-infected adults Wu, Songjie Zhang, Yubin Ming, Fangzhao Zou, Shi Wu, Mengmeng Guo, Wei Tang, Weiming Liang, Ke AIDS Res Ther Short Report This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccination dose. The overall AE frequency was 22.8% after dose one, which was higher than after dose two (10.2%) (P < 0.001). No severe side event or vaccine safety concern was observed. Our finding was essential in reducing vaccine hesitancy among PLWH. BioMed Central 2021-12-04 /pmc/articles/PMC8643182/ /pubmed/34863210 http://dx.doi.org/10.1186/s12981-021-00416-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Wu, Songjie
Zhang, Yubin
Ming, Fangzhao
Zou, Shi
Wu, Mengmeng
Guo, Wei
Tang, Weiming
Liang, Ke
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_full Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_fullStr Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_full_unstemmed Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_short Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_sort adverse events of inactivated covid-19 vaccine in hiv-infected adults
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643182/
https://www.ncbi.nlm.nih.gov/pubmed/34863210
http://dx.doi.org/10.1186/s12981-021-00416-1
work_keys_str_mv AT wusongjie adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT zhangyubin adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT mingfangzhao adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT zoushi adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT wumengmeng adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT guowei adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT tangweiming adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
AT liangke adverseeventsofinactivatedcovid19vaccineinhivinfectedadults

Ejemplares similares